Area of Operations
InternationalH. Lundbeck AS
Lundbeck is a global pharmaceutical company working with Brain disorders
Lundbeck markets a number of different pharmaceuticals for the treatment of disorders of the central nervous system (CNS). The most recently launched compounds include: Cipralex®/Lexapro® (depression), Ebixa® (Alzheimer’s disease), Azilect® (Parkinson’s disease), Xenazine® (chorea associated with Huntington's disease), Serdolect® (schizophrenia) and Sabril® (epilepsy).
Lundbeck employs 5.900 people worldwide, 2.000 of whom are based in Denmark. We have employees in 57 countries, and our products are registered in more than 100 countries. We have production facilities in Italy, France, Mexico and Denmark and research centres in Denmark and the USA. Lundbeck generated revenue of approximately DKK 14,8 billion in 2010.
Address
- Street: Strandveien 15 B
- Postcode: 1366
- City: LYSAKER
- Country: Norway
Contact
- Website: http://www.lundbeck.com/
On the map
Fill in your address into the address field below the map and the shortest route will be calculated.
Supported by 
Comments (0)